We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...
Amgen and UCB have suffered another setback as they try to build momentum for Evenity, their new antibody therapy for osteoporosis. The EMA’s Committee for Medicinal Products for Human Use (CHMP ...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
With a market cap of $142 billion, Amgen has been a pioneer in the biotechnology industry for over 40 years. Its portfolio includes treatments for cancer, heart disease, osteoporosis, inflammatory ...
Its strategic focus encompasses diverse therapeutic areas, such as oncology and cardiovascular disease ... for the quarter (up 3%). These products underscore Amgen's capacity to seize growth ...
Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
Management anticipates continued growth in key products like Repatha ... pressures in obesity and cardiovascular markets, emphasizing the need for differentiation. Amgen delivered strong financial ...